Planet 13 Holdings (PLNH) Revenue Growth (3y) (2024 - 2026)
Planet 13 Holdings (PLNH) Revenue Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 2.94% |
| 10 | Planet 13 Holdings | 39.32 Mn | 23.06 Mn | 9.41 Mn | -5.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.40% |
| Dec 31, 2025 | 0.50% |
| Sep 30, 2025 | -3.16% |
| Jun 30, 2025 | -1.86% |
| Mar 31, 2025 | 2.94% |
| Dec 31, 2024 | 0.45% |
| Sep 30, 2024 | -0.81% |
| Jun 30, 2024 | 112.38% |
| Mar 31, 2024 | -1.33% |